- Release Date: 13/12/22 08:33
- Summary: RAD201 HER2 nanobody demonstrates favourable tumor targeting
- Price Sensitive: No
- Download Document 132.23KB
- Forums
- ASX - By Stock
- RAD
- Ann: RAD201 HER2 nanobody demonstrates favourable tumor targeting
Ann: RAD201 HER2 nanobody demonstrates favourable tumor targeting
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAD (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
-0.003(7.32%) |
Mkt cap ! $17.95M |
Open | High | Low | Value | Volume |
3.8¢ | 4.0¢ | 3.7¢ | $114.3K | 2.988M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38762 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 594686 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38762 | 0.038 |
11 | 1959258 | 0.037 |
4 | 278949 | 0.036 |
7 | 1152270 | 0.035 |
2 | 162000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 594686 | 7 |
0.040 | 639762 | 5 |
0.042 | 526257 | 3 |
0.043 | 100000 | 1 |
0.044 | 100000 | 1 |
Last trade - 13.37pm 28/06/2024 (20 minute delay) ? |
Featured News
RAD (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online